Universities and colleges
Cancer scientists in the United States have been studying the mechanism by which DNA repair prevents DNA damage-induced apoptosis, or cell death. A team of researchers from Wayne State University discovered that the Bcl-x(L) protein plays a crucial role in this process. By studying normal human fibroblasts and fibroblasts
Universities and colleges
A recent study published in Cancer Research reveals that nitric oxide (NO) plays a significant role in the development of cervical cancer in human papillomavirus (HPV)-infected cells. The researchers, led by L.L. Wei and colleagues at the University of New Mexico, found that exposure to NO increased HPV
Universities and colleges
Researchers in Onderstepoort, South Africa, evaluated the antiangiogenic effects of two compounds, 2-aryl-3-bromoquinolin-4(1H)-ones and 2-aryl-3-bromo-1-methylquinolin-4(1H)-one, with promising results. These compounds showed increased cytotoxicity at higher doses and inhibited neovessel growth in an ex vivo assay of angiogenesis. The study suggests that these compounds may exhibit antiangiogenic
Universities and colleges
Researchers at the University of Colorado have shed light on the role of c-Jun N-terminal kinases (JNKs) in regulating apoptosis in endometrial cancer cells. In a study published in Apoptosis, the researchers investigated the effects of JNK activation and inhibition on apoptosis in Ishikawa and HEC-50 cells, models of type
Universities and colleges
Recent research in the journal Cancer Chemotherapy and Pharmacology has found that zebularine, a DNA methyltransferase inhibitor, has a suppressive effect on 5-fluorouracil (5-FU)-induced apoptosis in human oral squamous cell carcinoma cells. The study, conducted by M. Suzuki and colleagues at Tohoku University, investigated the chemosensitivity of 5-FU and
Universities and colleges
Elderly or poor performance status patients with unresectable non-small cell lung cancer (NSCLC) may benefit from a 4-week schedule of combination chemotherapy consisting of gemcitabine and cisplatin. This treatment regimen was investigated in a study of 48 patients with previously untreated NSCLC. Results showed a partial response and stable disease
Universities and colleges
Colorectal carcinoma is a type of cancer that affects the colon and rectum, with chemotherapy being a primary treatment option. 5-Fluorouracil (5-FU) is a chemotherapy drug that targets thymidylate synthase (TS), an enzyme essential for DNA replication. However, previous studies have yielded inconsistent results on the correlation between TS protein
Universities and colleges
Recent research from Shanghai, China, has shown that RNA interference (RNAi) targeting the c-Met gene can effectively inhibit the growth and metastasis of glioma cells. The study, conducted by researchers at Shanghai Jiao Tong University, used RNAi technology to downregulate the expression of c-Met, a receptor tyrosine kinase involved in
Universities and colleges
Scientists have discovered a crucial link between FGF15 signaling and the regulation of hepatic bile acid metabolism and insulin action. According to a study published in the Journal of Biological Chemistry, FGF15 signaling decreases hepatic forkhead transcription factor 1 (FoxO1) activity through phosphatidylinositol (PI) 3-kinase-dependent phosphorylation. This process is activated
Universities and colleges
Research conducted by W.S. Yan and colleagues at the University of California has discovered a novel mechanism by which mutant p53 acquires its gain of function in cancer cells. The study found that mutant p53 can transactivate the GRO1 gene, leading to increased expression and contributing to cancer progression,
Universities and colleges
Researchers in Suita, Japan have identified a molecular target associated with the progression of gastric cancer, a tumor suppressor gene called FBXW7. This gene is transcriptionally controlled by p53 and plays a crucial role in cell cycle regulation. The study found that low expression levels of FBXW7 in primary gastric
Universities and colleges
Researchers from Cardiff University have made significant strides in the fight against breast cancer, discovering a novel approach to treating tumors caused by mutations in the BRCA2 gene. The study, published in Cancer Research, found that inhibition of poly(ADP-ribose) polymerase-1 (PARP-1) effectively regresses tumors in mice with deficiencies in
